$0
$1.33 Million
0.0% of portfolio
42,246
Q2 2024
Added 4.71%
$0
$11,000
0.0% of portfolio
237
Q2 2024
Added 0.85%
-
$0
0.0% of portfolio
-
Q2 2024
New
$0
$310,000
0.0% of portfolio
2,906
Q2 2024
Added 68.95%
$0
$35,000
0.0% of portfolio
319
Q4 2023
Reduced 96.33%
$0
$13,000
0.0% of portfolio
218
Q2 2024
New
$163M
$17,000
0.0% of portfolio
20,000
Q4 2022
Reduced 1.23%
$2.58B
$411,000
0.0% of portfolio
26,176
Q1 2024
Added 0.38%
$1.89B
$1.5 Million
0.0% of portfolio
26,139
Q2 2024
Reduced 29.35%
$14B
$1.41 Million
0.0% of portfolio
17,743
Q2 2024
Reduced 0.88%
$9.18B
$857,000
0.0% of portfolio
32,718
Q2 2024
Added 18.3%
$1.57B
$436,000
0.0% of portfolio
7,592
Q2 2024
Reduced 0.17%
-
$0
0.0% of portfolio
-
Q1 2021
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 0.21%
-
$0
0.0% of portfolio
-
Q2 2024
New
$48.5B
$334,000
0.0% of portfolio
40,449
Q2 2024
Added 21.0%
$8.68B
$16,000
0.0% of portfolio
312
Q2 2024
New
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$3.04B
$324,000
0.0% of portfolio
10,977
Q2 2024
Added 1.16%
$36.7B
$734,000
0.0% of portfolio
7,310
Q2 2024
Added 17.6%
$9.49B
$1.35 Million
0.0% of portfolio
23,062
Q2 2024
Added 0.33%
$2.93B
$344,000
0.0% of portfolio
27,986
Q1 2024
Reduced 2.42%
$116B
$1.03 Million
0.0% of portfolio
15,947
Q2 2024
Added 4.13%
$462M
$118,000
0.0% of portfolio
18,594
Q2 2024
New
$10.2B
$204,000
0.0% of portfolio
10,768
Q2 2024
Added 2.21%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 25.56%
$9.58B
$427,000
0.0% of portfolio
6,665
Q2 2024
Added 15.65%
$0
$13,000
0.0% of portfolio
5,602
Q4 2023
Reduced 0.11%
$999M
$40,000
0.0% of portfolio
11,337
Q2 2024
Reduced 10.1%
$39.8B
$642,000
0.0% of portfolio
4,354
Q2 2024
Reduced 18.48%
$22.1B
$973,000
0.0% of portfolio
45,975
Q2 2024
Added 2.11%
$58.6B
$595,000
0.0% of portfolio
2,728
Q2 2024
Reduced 0.87%
$3.29B
$454,000
0.0% of portfolio
22,500
Q2 2024
Added 2.05%
$689M
$385,000
0.0% of portfolio
31,200
Q4 2023
Reduced 2.5%
$17.5B
$220,000
0.0% of portfolio
7,238
Q2 2024
Added 14.87%
$174B
$524,000
0.0% of portfolio
12,056
Q2 2024
Reduced 2.96%
$1.46B
$678,000
0.0% of portfolio
15,755
Q2 2024
Reduced 6.76%
$23.6B
$1.18 Million
0.0% of portfolio
1,995
Q2 2024
Added 39.8%
$10.5B
$778,000
0.0% of portfolio
3,162
Q2 2024
Added 121.58%
$2.23B
$1.02 Million
0.0% of portfolio
10,331
Q2 2024
Reduced 1.72%
$7.3B
$256,000
0.0% of portfolio
1,691
Q2 2024
Added 1.02%
$5.23B
$407,000
0.0% of portfolio
4,375
Q2 2024
Added 78.79%
$15.1B
$612,000
0.0% of portfolio
3,042
Q2 2024
Reduced 2.0%
$1.43B
$1.31 Million
0.0% of portfolio
206,800
Q2 2024
Reduced 34.04%
$14.1B
$1.31 Million
0.0% of portfolio
21,629
Q2 2024
Reduced 40.04%
$1.4B
$288,000
0.0% of portfolio
47,400
Q2 2024
Reduced 0.21%
$36.7B
$1.16 Million
0.0% of portfolio
12,749
Q2 2024
Added 2.67%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 51.59%
$0
$874,000
0.0% of portfolio
14,713
Q3 2023
New
$0
$1.18 Million
0.0% of portfolio
42,799
Q3 2023
New